PMC:7441788 / 4210-5259
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T13 | 10-15 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T14 | 913-918 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T43 | 58-66 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T44 | 188-196 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T45 | 254-263 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T46 | 315-323 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T47 | 498-516 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T48 | 507-516 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T49 | 699-708 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T32 | 3-15 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | VeroE6 cells |
T33 | 31-39 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T34 | 100-102 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
T35 | 297-300 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T36 | 324-332 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T37 | 359-362 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T38 | 368-369 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T39 | 387-388 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T40 | 427-433 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T41 | 646-651 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T42 | 673-679 | http://purl.obolibrary.org/obo/CLO_0001751 | denotes | and 33 |
T43 | 725-727 | http://purl.obolibrary.org/obo/CLO_0001527 | denotes | 94 |
T44 | 761-766 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T45 | 857-858 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T46 | 906-918 | http://purl.obolibrary.org/obo/CLO_0051972 | denotes | HRT-18 cells |
T47 | 906-918 | http://purl.obolibrary.org/obo/CLO_0051973 | denotes | HRT-18 cells |
T48 | 906-912 | http://purl.obolibrary.org/obo/CLO_0003836 | denotes | HRT-18 |
T49 | 934-942 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T49 | 21-30 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T50 | 43-45 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T51 | 146-148 | Chemical | denotes | SI | http://purl.obolibrary.org/obo/CHEBI_90326 |
T52 | 160-162 | Chemical | denotes | SI | http://purl.obolibrary.org/obo/CHEBI_90326 |
T53 | 239-241 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T54 | 294-296 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T55 | 356-358 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T56 | 460-462 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T57 | 550-552 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T58 | 615-617 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T59 | 742-744 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T60 | 839-848 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T61 | 883-885 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T62 | 924-933 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T63 | 946-948 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T64 | 1032-1034 | Chemical | denotes | SI | http://purl.obolibrary.org/obo/CHEBI_90326 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T32 | 43-45 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T33 | 239-241 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T34 | 294-296 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T35 | 356-358 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T36 | 460-462 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T37 | 550-552 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T38 | 615-617 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T39 | 742-744 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T40 | 883-885 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T41 | 946-948 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T43 | 58-66 | Species | denotes | SARS-CoV | NCBItxid:694009 |
T44 | 188-196 | Species | denotes | SARS-CoV | NCBItxid:694009 |
T45 | 315-323 | Species | denotes | SARS-CoV | NCBItxid:694009 |
T46 | 498-506 | Species | denotes | SARS-CoV | NCBItxid:694009 |
T47 | 957-966 | Species | denotes | HCoV-OC43 | NCBItxid:31631 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T36 | 0-187 | Sentence | denotes | In VeroE6 cells, the antiviral activity of CQ/HCQ against SARS-CoV had an EC50 of 4.1 (±1.0) μM and 34(±5) μM, CC50 of >128 μM and CC50 > 100 and SI of >31 and SI>3, respectively [10,11]. |
T37 | 188-269 | Sentence | denotes | SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. |
T38 | 270-342 | Sentence | denotes | The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. |
T39 | 343-411 | Sentence | denotes | In addition, CQ has both a prophylactic and a therapeutic advantage. |
T40 | 412-902 | Sentence | denotes | Vincent et al. tested various concentrations of CQ (0.1–10 µM) added 20–24 h prior to SARS-CoV infection and found that 0.1, 1, and 10 µM CQ reduced infectivity by 28%, 53%, and 100%, respectively; when CQ was added immediately after virus adsorption, 0.1–1 µM and 33–100 µM reduced the infection by 50% up to 90–94%; addition of CQ 3 and 5 h after virus adsorption was still significantly effective, yet to achieve equivalent antiviral effect, a higher concentration of CQ was needed [13]. |
T41 | 903-1049 | Sentence | denotes | In HRT-18 cells, the antiviral activity of CQ against HCoV-OC43 had an EC50 of 0.306 (±0.091) μM, CC50 of 419.0 (±192.5) μM, and SI of 1.369 [14]. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
194 | 107-109 | Gene | denotes | μM | Gene:56925 |
195 | 997-999 | Gene | denotes | μM | Gene:56925 |
196 | 1024-1026 | Gene | denotes | μM | Gene:56925 |
197 | 236-238 | Gene | denotes | μM | Gene:56925 |
198 | 124-126 | Gene | denotes | μM | Gene:56925 |
199 | 93-95 | Gene | denotes | μM | Gene:56925 |
200 | 58-66 | Species | denotes | SARS-CoV | Tax:694009 |
201 | 188-196 | Species | denotes | SARS-CoV | Tax:694009 |
202 | 957-966 | Species | denotes | HCoV-OC43 | Tax:31631 |
203 | 315-323 | Species | denotes | SARS-CoV | Tax:694009 |
204 | 43-45 | Chemical | denotes | CQ | MESH:D002738 |
205 | 46-49 | Chemical | denotes | HCQ | MESH:D006886 |
206 | 239-241 | Chemical | denotes | CQ | MESH:D002738 |
207 | 294-296 | Chemical | denotes | CQ | MESH:D002738 |
208 | 338-341 | Chemical | denotes | HCQ | MESH:D006886 |
209 | 356-358 | Chemical | denotes | CQ | MESH:D002738 |
210 | 946-948 | Chemical | denotes | CQ | MESH:D002738 |
211 | 254-263 | Disease | denotes | infection | MESH:D007239 |
212 | 498-516 | Disease | denotes | SARS-CoV infection | MESH:C000657245 |
213 | 699-708 | Disease | denotes | infection | MESH:D007239 |
214 | 3-9 | CellLine | denotes | VeroE6 | CVCL:0574 |
215 | 906-912 | CellLine | denotes | HRT-18 | CVCL:2514 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T30 | 10-15 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
T31 | 21-30 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | antiviral |
T32 | 197-208 | http://purl.obolibrary.org/obo/IDO_0000608 | denotes | replication |
T33 | 254-263 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T34 | 507-516 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T35 | 561-572 | http://purl.obolibrary.org/obo/IDO_0000464 | denotes | infectivity |
T36 | 646-651 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T37 | 699-708 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T38 | 761-766 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T39 | 839-848 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | antiviral |
T40 | 913-918 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
T41 | 924-933 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | antiviral |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T13 | 10-15 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T14 | 913-918 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T37 | 58-66 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T38 | 188-196 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T39 | 254-263 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T40 | 315-323 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T41 | 498-516 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T42 | 699-708 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
194 | 107-109 | Gene | denotes | μM | Gene:56925 |
195 | 997-999 | Gene | denotes | μM | Gene:56925 |
196 | 1024-1026 | Gene | denotes | μM | Gene:56925 |
197 | 236-238 | Gene | denotes | μM | Gene:56925 |
198 | 124-126 | Gene | denotes | μM | Gene:56925 |
199 | 93-95 | Gene | denotes | μM | Gene:56925 |
200 | 58-66 | Species | denotes | SARS-CoV | Tax:694009 |
201 | 188-196 | Species | denotes | SARS-CoV | Tax:694009 |
202 | 957-966 | Species | denotes | HCoV-OC43 | Tax:31631 |
203 | 315-323 | Species | denotes | SARS-CoV | Tax:694009 |
204 | 43-45 | Chemical | denotes | CQ | MESH:D002738 |
205 | 46-49 | Chemical | denotes | HCQ | MESH:D006886 |
206 | 239-241 | Chemical | denotes | CQ | MESH:D002738 |
207 | 294-296 | Chemical | denotes | CQ | MESH:D002738 |
208 | 338-341 | Chemical | denotes | HCQ | MESH:D006886 |
209 | 356-358 | Chemical | denotes | CQ | MESH:D002738 |
210 | 946-948 | Chemical | denotes | CQ | MESH:D002738 |
211 | 254-263 | Disease | denotes | infection | MESH:D007239 |
212 | 498-516 | Disease | denotes | SARS-CoV infection | MESH:C000657245 |
213 | 699-708 | Disease | denotes | infection | MESH:D007239 |
214 | 3-9 | CellLine | denotes | VeroE6 | CVCL:0574 |
215 | 906-912 | CellLine | denotes | HRT-18 | CVCL:2514 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T36 | 0-187 | Sentence | denotes | In VeroE6 cells, the antiviral activity of CQ/HCQ against SARS-CoV had an EC50 of 4.1 (±1.0) μM and 34(±5) μM, CC50 of >128 μM and CC50 > 100 and SI of >31 and SI>3, respectively [10,11]. |
T37 | 188-269 | Sentence | denotes | SARS-CoV replication was inhibited by 99% at 16 μM CQ 3 days post-infection [12]. |
T38 | 270-342 | Sentence | denotes | The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. |
T39 | 343-411 | Sentence | denotes | In addition, CQ has both a prophylactic and a therapeutic advantage. |
T40 | 412-902 | Sentence | denotes | Vincent et al. tested various concentrations of CQ (0.1–10 µM) added 20–24 h prior to SARS-CoV infection and found that 0.1, 1, and 10 µM CQ reduced infectivity by 28%, 53%, and 100%, respectively; when CQ was added immediately after virus adsorption, 0.1–1 µM and 33–100 µM reduced the infection by 50% up to 90–94%; addition of CQ 3 and 5 h after virus adsorption was still significantly effective, yet to achieve equivalent antiviral effect, a higher concentration of CQ was needed [13]. |
T41 | 903-1049 | Sentence | denotes | In HRT-18 cells, the antiviral activity of CQ against HCoV-OC43 had an EC50 of 0.306 (±0.091) μM, CC50 of 419.0 (±192.5) μM, and SI of 1.369 [14]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32496926-24841269-132195657 | 180-182 | 24841269 | denotes | 10 |
32496926-16640347-132195658 | 183-185 | 16640347 | denotes | 11 |
32496926-15351731-132195659 | 265-267 | 15351731 | denotes | 12 |
32496926-16115318-132195660 | 898-900 | 16115318 | denotes | 13 |
32496926-19506054-132195661 | 1045-1047 | 19506054 | denotes | 14 |